Lexeo Therapeutics, Inc.·4

Jun 29, 4:45 PM ET

Agger Mette Kirstine 4

4 · Lexeo Therapeutics, Inc. · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Lexeo (LXEO) Director Mette Agger Receives 35,000-Share Award

What Happened

  • Agger Mette Kirstine (listed as a Director) was granted 35,000 derivative securities (reported as an award/acquisition) on 2026-06-25. The filing reports $0.00 paid for the award (no cash transaction reported). This is a grant of convertible/derivative compensation rather than an open-market purchase or sale.

Key Details

  • Transaction date: 2026-06-25; Form 4 filed: 2026-06-29 (filed within the SEC’s two-business-day window).
  • Amount granted: 35,000 derivative securities; reported price: $0.00; total cash value not reported.
  • Shares owned after transaction: not specified in this filing.
  • Footnote: 100% of the shares underlying the option will vest and become exercisable on the earlier of one year after the grant date or the next annual meeting of stockholders, subject to continuous service.
  • Transaction type: Award/Grant (code A); derivative security (option-like award).

Context

  • This appears to be a standard equity compensation grant to a director intended for retention/compensation. It is not an immediate purchase or sale of common stock and does not by itself indicate a buy/sell signal. Exercise terms (exercise price, post-vesting disposition) and eventual value will depend on additional plan details not included in this Form 4.

Insider Transaction Report

Form 4
Period: 2026-06-25
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-06-25+35,00035,000 total
    Exercise: $4.70Exp: 2036-06-24Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date.
Signature
/s/ Youjin Choi, Attorney-in-Fact|2026-06-29

Documents

1 file
  • 4
    form4-06292026_080602.xmlPrimary